首页> 外文期刊>Oncology reports >Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer.
【24h】

Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer.

机译:肿瘤浸润的CD4 + Th17细胞在肿瘤微环境中产生IL-17,并促进人胃癌的肿瘤进展。

获取原文
获取原文并翻译 | 示例
       

摘要

Recently, a subset of IL-17 producing T cells distinct from Th1 or Th2 cells has been described as key players in inflammation and autoimmune diseases as well as cancer development. In this study, we investigated the expression level of IL-17 and T helper 17 (Th17)-related cytokines in gastric cancer tissues and assessed the association of their expression with angiogenesis and their clinicopathological parameters. Tumor and adjacent normal tissues were obtained from 82 patients with gastric cancer. IL-17, IL-21 and IL-23 mRNA expression levels were quantified by real-time RT-PCR. Th17 infiltration, microvessel density and neutrophil infiltration in tumor tissues were examined by immunohistochemistry and double immunofluorescence histochemistry. Expression of IL-17, IL-21 and IL-23 mRNA was found to be significantly up-regulated in tumor tissues compared with adjacent normal tissues. The expression level of IL-17 mRNA strongly and positively correlated with that of IL-21 mRNA in tumor tissue. The number of vascular endothelial cells and infiltrating neutrophils was significantly larger in tumors expressing a high level of IL-17 mRNA than in tumors expressing a low level of IL-17 mRNA. In tumor tissues most CD4+ cells were stained with anti-IL-17 antibody. The expression level of IL-17 mRNA in gastric tumors was associated with the depth of the tumors, lymph-vascular invasion and lymph node involvement, suggesting that IL-17 obviously was related to tumor progression. IL-17 and IL-21, which regulates IL-17, would be potential therapeutic targets for the treatment of gastric cancer.
机译:最近,已描述了与Th1或Th2细胞不同的,产生IL-17的T细胞的子集,它是炎症和自身免疫性疾病以及癌症发展的关键因素。在这项研究中,我们调查了IL-17和T辅助17(Th17)相关细胞因子在胃癌组织中的表达水平,并评估了它们与血管生成的表达及其临床病理参数之间的关系。从82例胃癌患者中获得肿瘤和邻近的正常组织。 IL-17,IL-21和IL-23 mRNA表达水平通过实时RT-PCR定量。通过免疫组织化学和双重免疫荧光组织化学检查肿瘤组织中的Th17浸润,微血管密度和中性粒细胞浸润。与邻近的正常组织相比,发现在肿瘤组织中IL-17,IL-21和IL-23 mRNA的表达显着上调。 IL-17 mRNA在肿瘤组织中的表达水平与IL-21 mRNA的表达呈正相关。表达高水平的IL-17 mRNA的肿瘤中血管内皮细胞和浸润的中性粒细胞的数量明显高于表达低水平的IL-17 mRNA的肿瘤。在肿瘤组织中,大多数CD4 +细胞均用抗IL-17抗体染色。胃肿瘤中IL-17 mRNA的表达水平与肿瘤的深度,淋巴管浸润和淋巴结受累有关,提示IL-17与肿瘤的进展有关。调节IL-17的IL-17和IL-21将成为治疗胃癌的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号